Log in Book a Demo

US Pharma & Biotech Infectious Diseases - PPC Market Share Analysis April 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Infectious Diseases category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Infectious Diseases brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
paxlovid.com 14.85
uqora.com 10.45
mavyret.com 8.26
prevnar20.com 5.63
cabenuva.com 5.51
hellowisp.com 5.49
epclusa.com 5.09
apretude.com 2.53
solvwellness.com 2.47
apretudeonline.com 2.32
others 37.4

Copyright © Adthena. All rights reserved.

Paxlovid.com leads with 14.85% click share, followed by Uqora.com at 10.45%. Mavyret.com captures 8.26%, while ‘others’ dominate with 37.4%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Infectious Diseases brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date cabenuva.com dovato.com mavyret.com biktarvy.com sunlenca.com sunlencahcp.com apretude.com epclusa.com paxlovid.com prevnar20.com
2025/04/01 0.03% 0% 0% 2.1% 4.13% 3.2% 0% 0% 0.01% 28.67%
2025/04/02 0% 0% 0% 0.02% 7.2% 6.14% 0% 0% 0.01% 18.16%
2025/04/03 0.87% 0% 0% 0% 6.88% 11.43% 0% 2.41% 0.01% 17.5%
2025/04/04 3.29% 6.4% 1.75% 7.8% 4.51% 6.54% 2.24% 2.64% 7.41% 14.08%
2025/04/05 6.98% 5.92% 5.99% 3.3% 3.07% 5.28% 5.38% 5.82% 3.18% 5.51%
2025/04/06 4.39% 6.76% 7.35% 4.27% 6.38% 6.68% 2.18% 5.82% 6.47% 6.26%
2025/04/07 3.19% 1.79% 17.26% 6.34% 2.28% 3.36% 5.03% 11.29% 4.33% 3.21%
2025/04/08 10.36% 4.25% 10.49% 6.01% 1.99% 3.78% 2.59% 8.64% 3.3% 3.67%
2025/04/09 14.42% 8.16% 7.56% 8.31% 2.62% 2.6% 2.91% 6.51% 1.57% 4.65%
2025/04/10 9.95% 4.42% 11.79% 9.3% 3.92% 3.15% 2.99% 10.66% 0.63% 4.2%
2025/04/11 8.09% 2.65% 9.22% 5.67% 1.59% 3.77% 8.07% 4.66% 4.12% 4.34%
2025/04/12 10.64% 4.11% 11.48% 4.81% 3.67% 5.16% 3.99% 6.5% 1.77% 7.55%
2025/04/13 8.96% 2.31% 8.25% 7.04% 3.7% 6.7% 5.12% 2.98% 8.91% 8.41%
2025/04/14 13.74% 9.89% 11.93% 6.28% 2.32% 4.48% 3.56% 5.68% 0.49% 7.39%
2025/04/15 11.1% 2.34% 7.91% 10.6% 3.54% 3.25% 2.98% 2.84% 2.42% 10.6%
2025/04/16 12.3% 1.47% 14.11% 5.68% 2.28% 1.6% 5.24% 6.57% 4.6% 6.5%
2025/04/17 10.27% 7.12% 6.05% 6.29% 1.94% 0.97% 4.76% 3.31% 9.31% 3.29%
2025/04/18 11.3% 9.17% 3.98% 8.42% 2.4% 1.18% 4.17% 3.21% 9.62% 0.86%
2025/04/19 15.18% 4.27% 17.71% 9.09% 3.33% 1.91% 3.87% 2.64% 2.38% 1.09%
2025/04/20 16.46% 11.02% 13.51% 9.09% 2.25% 1.67% 5.42% 7.25% 1.19% 2.71%
2025/04/21 4.39% 4.16% 15.52% 9.58% 3.52% 1.61% 5.37% 7.18% 1.81% 1.28%
2025/04/22 11.41% 9.91% 3.84% 9.47% 2.55% 1.93% 4.06% 5.06% 0.64% 2.56%
2025/04/23 6.39% 9.73% 4.43% 10.26% 3.74% 3.82% 3.63% 1.42% 7.39% 2.77%
2025/04/24 10.25% 2.73% 7.99% 7.36% 1.3% 2.52% 6.1% 6.37% 0.62% 0.09%
2025/04/25 7.02% 10.68% 1.03% 6.77% 1.95% 2.86% 1.03% 2.67% 4.26% 2.36%
2025/04/26 3.79% 8.06% 0.9% 7.55% 1.89% 3.02% 6.79% 4.32% 9.07% 3.77%
2025/04/27 2.77% 10.04% 6.16% 15.89% 1.54% 3.33% 3.37% 4.18% 7.63% 7.14%
2025/04/28 8.29% 4.96% 7.28% 12.71% 4.3% 6.42% 6.75% 8.41% 5.61% 0.1%
2025/04/29 16.21% 7.03% 6.52% 7.42% 4.59% 4.65% 1.4% 3.09% 6.78% 4.75%
2025/04/30 17.49% 12.15% 7.9% 7.21% 5.81% 5.78% 5.47% 4.64% 2.89% 0.01%

Copyright © Adthena. All rights reserved.

April saw cabenuva.com rise from 0.03% to 17.49%, while prevnar20.com dropped from 28.67% to 0.01%.

Market Exposure

Competitor Count for US Pharma & Biotech Infectious Diseases

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/04/01 48
2025/04/02 53
2025/04/03 51
2025/04/04 80
2025/04/05 84
2025/04/06 83
2025/04/07 86
2025/04/08 86
2025/04/09 83
2025/04/10 83
2025/04/11 83
2025/04/12 75
2025/04/13 76
2025/04/14 75
2025/04/15 68
2025/04/16 73
2025/04/17 83
2025/04/18 68
2025/04/19 74
2025/04/20 73
2025/04/21 76
2025/04/22 78
2025/04/23 80
2025/04/24 80
2025/04/25 75
2025/04/26 76
2025/04/27 70
2025/04/28 77
2025/04/29 70
2025/04/30 59

Copyright © Adthena. All rights reserved.

April began with 48 advertisers, peaking at 86 by the 7th. Mid-month saw fluctuations, stabilizing around 80. The month concluded with a dip to 59.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Infectious Diseases

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
paxlovid.com 6.33%
uqora.com 3.84%
dovatohcp.com 1.72%
dovato.com 1.62%
callondoc.com 1.27%
comirnaty.com -1.34%
goodrx.com -1.8%
mavyret.com -1.94%
epclusa.com -2.04%
prevnar20.com -5.62%

Copyright © Adthena. All rights reserved.

Paxlovid.com surged with a 6.33% click share increase, while prevnar20.com dropped by 5.62%. Uqora.com rose 3.84%, contrasting epclusa.com’s 2.04% decline.

Campaign Efficiency

US Pharma & Biotech Infectious Diseases Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date uqora.com hellowisp.com cabenuva.com mavyret.com apretude.com apretudeonline.com epclusa.com paxlovid.com descovy.com prevnar20.com
2025/04/01 40.08% 16.06% 0.01% 0% 0% 0% 0% 0% 0% 9.04%
2025/04/02 28.5% 14.31% 0% 0% 0% 0% 0% 0% 0% 6.48%
2025/04/03 0% 9.52% 0.84% 0% 0% 0% 0.87% 0.01% 0% 9.86%
2025/04/04 0.3% 3.79% 3.41% 1.72% 1.58% 1.41% 1.85% 5.92% 0% 7.84%
2025/04/05 9.39% 2.6% 5.76% 7.07% 4.16% 2.29% 4.68% 3.58% 0.16% 3.14%
2025/04/06 14.28% 2.97% 2.71% 6.31% 1.46% 2.01% 4.47% 4.93% 1.32% 2.57%
2025/04/07 15.25% 1.34% 2.41% 18.65% 2.83% 1.74% 11.82% 4.07% 3.84% 1.76%
2025/04/08 0% 4.44% 5.92% 11.6% 2.41% 9.37% 6.64% 2.85% 1.72% 2.17%
2025/04/09 0% 2.07% 7.37% 13.43% 4.24% 1.48% 9% 2.01% 2.54% 4.04%
2025/04/10 3.94% 5.08% 6.4% 14.83% 3.15% 5.73% 11.36% 0.42% 2.39% 2.72%
2025/04/11 12.52% 11.08% 6.21% 8.39% 4.87% 3.67% 3.7% 3.11% 1.89% 2.13%
2025/04/12 2.86% 12.24% 7.44% 14.13% 3.94% 3.57% 7.62% 1.64% 1.74% 4.83%
2025/04/13 8.71% 18.95% 4.38% 7.25% 3.95% 1.07% 1.79% 6.41% 0.05% 3.92%
2025/04/14 4.79% 3.32% 7.74% 15.45% 3.24% 1.37% 5.46% 0.47% 3.8% 5.38%
2025/04/15 0% 10.05% 4.82% 10.85% 3.28% 1.56% 1.76% 2.88% 4.78% 7.49%
2025/04/16 17.21% 7.21% 6.53% 13.99% 3.98% 4.95% 5.75% 3.6% 1.94% 3.31%
2025/04/17 4.98% 8.04% 5.12% 6.27% 3.87% 5.17% 3.18% 7.8% 3.58% 1.86%
2025/04/18 0% 10.8% 5.84% 5.46% 3.16% 2.48% 2.63% 10.16% 3.22% 0.58%
2025/04/19 0% 0.07% 7.86% 28.69% 3.78% 3.23% 3.16% 2.84% 5.99% 1.03%
2025/04/20 9.52% 1.09% 10.55% 18.9% 5.53% 3.02% 9.45% 1.26% 4.27% 2.15%
2025/04/21 4.29% 0.06% 4.27% 20.47% 3.96% 3.83% 8.38% 1.75% 11.53% 1.01%
2025/04/22 19.63% 3.98% 6.05% 3.93% 2.9% 5.2% 3.03% 0.46% 9.34% 1.8%
2025/04/23 15.56% 2.65% 3.15% 5.68% 3.34% 2.37% 0.55% 7.57% 0.05% 1.83%
2025/04/24 5.44% 0.05% 8.87% 10.22% 5.85% 7.78% 6.99% 0.76% 2.5% 0.06%
2025/04/25 46.43% 6.21% 2.06% 0.42% 0.47% 1.49% 0.93% 1.99% 2.08% 0.72%
2025/04/26 30.91% 4.44% 2.52% 0.65% 4.15% 2.51% 2.36% 7.29% 3.2% 2.01%
2025/04/27 0% 13.84% 2.22% 8.15% 3.89% 1.24% 1.89% 8.35% 9.25% 6.25%
2025/04/28 0% 0.09% 8.35% 10.73% 7.85% 1.33% 10.85% 9.26% 8.91% 0.08%
2025/04/29 13.49% 6.76% 5.76% 7.04% 1.14% 0.96% 2.45% 6.05% 0.02% 3.01%
2025/04/30 14.12% 11.32% 10.58% 8.87% 5.14% 3.89% 3.46% 2.55% 1.9% 0.01%

Copyright © Adthena. All rights reserved.

April saw dynamic shifts in PPC impressions. Uqora.com started strong, dipped mid-month, then surged to 46.43% on April 25. Hellowisp.com fluctuated, peaking at 18.95% on April 13. Cabenuva.com maintained steady growth, ending at 10.58%. Mavyret.com had a notable spike on April 19 with 28.69%. Overall, the month concluded with diverse performance across domains.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Infectious Diseases

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    Medication For HIV Prevention - Pre-Exposure Prophylaxis Rx Prescription treatment website

    Schedule A Telehealth Appointment. Learn The Next Steps For Getting Started On PrEP Today.

  2. 2
    Did You Get A COVID-19 Shot? - Find Info On Side Effects Prescription vaccine website

    Learn About A 2024-2025 Formula COVID-19 Vaccine Option For 12 Yrs & Older.

  3. 3
    Hepatitis C Treatment Option - Cost Of Hep C Medication Prescription treatment website

    No Symptoms? Still Take Hep C Seriously. Discuss Treatment With A Healthcare Professional.

  4. 4
    PAXLOVID™ Treatment Rx - Safety & Side Effects https://www.paxlovid.com/

    PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) Rx Info, Safety Info & Boxed Warning. View Additional Information To Share With Your Doctor When Discussing PAXLOVID™. Side Effects. FAQs.

  5. 5
    PREVNAR 20® By Pfizer - See Vaccine Information https://www.prevnar20.com

    Talk To Your Doctor About PREVNAR 20® (Pneumococcal 20-valent Conjugate Vaccine). Visit The Official Site To Find Patient Safety & Prescribing Info For PREVNAR 20®.

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, top-performing PPC ads reveal a focus on prevention and treatment. Apretudeonline.com emphasizes HIV prevention with telehealth appointments, while comirnaty.com addresses COVID-19 vaccine updates. Mavyret.com highlights Hepatitis C treatment, paxlovid.com provides safety info for COVID-19 treatment, and prevnar20.com promotes pneumococcal vaccination.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

US
Pharma & Biotech

US Pharmacology

US
Pharma & Biotech

US Research and Development

US
Pharma & Biotech

US Pulmonology

UK
Pharma & Biotech

UK Pharmacology